S&P 500   3,279.93 (-0.91%)
DOW   26,463.07 (-0.74%)
QQQ   274.15 (-0.81%)
AAPL   109.91 (-4.69%)
MSFT   203.51 (-0.59%)
FB   271.43 (-3.35%)
GOOGL   1,653.16 (+6.18%)
AMZN   3,095.89 (-3.59%)
TSLA   398.84 (-2.92%)
NVDA   510.82 (-1.95%)
BABA   309.05 (-1.12%)
CGC   18.66 (-0.64%)
GE   7.37 (+0.00%)
MU   50.00 (-0.95%)
AMD   76.01 (-2.58%)
T   26.80 (+0.15%)
F   7.79 (-1.39%)
ACB   3.97 (-2.93%)
GILD   58.14 (-0.67%)
NIO   30.44 (-4.85%)
NFLX   494.47 (-1.93%)
BA   147.41 (-0.59%)
DIS   121.00 (-0.44%)
S&P 500   3,279.93 (-0.91%)
DOW   26,463.07 (-0.74%)
QQQ   274.15 (-0.81%)
AAPL   109.91 (-4.69%)
MSFT   203.51 (-0.59%)
FB   271.43 (-3.35%)
GOOGL   1,653.16 (+6.18%)
AMZN   3,095.89 (-3.59%)
TSLA   398.84 (-2.92%)
NVDA   510.82 (-1.95%)
BABA   309.05 (-1.12%)
CGC   18.66 (-0.64%)
GE   7.37 (+0.00%)
MU   50.00 (-0.95%)
AMD   76.01 (-2.58%)
T   26.80 (+0.15%)
F   7.79 (-1.39%)
ACB   3.97 (-2.93%)
GILD   58.14 (-0.67%)
NIO   30.44 (-4.85%)
NFLX   494.47 (-1.93%)
BA   147.41 (-0.59%)
DIS   121.00 (-0.44%)
S&P 500   3,279.93 (-0.91%)
DOW   26,463.07 (-0.74%)
QQQ   274.15 (-0.81%)
AAPL   109.91 (-4.69%)
MSFT   203.51 (-0.59%)
FB   271.43 (-3.35%)
GOOGL   1,653.16 (+6.18%)
AMZN   3,095.89 (-3.59%)
TSLA   398.84 (-2.92%)
NVDA   510.82 (-1.95%)
BABA   309.05 (-1.12%)
CGC   18.66 (-0.64%)
GE   7.37 (+0.00%)
MU   50.00 (-0.95%)
AMD   76.01 (-2.58%)
T   26.80 (+0.15%)
F   7.79 (-1.39%)
ACB   3.97 (-2.93%)
GILD   58.14 (-0.67%)
NIO   30.44 (-4.85%)
NFLX   494.47 (-1.93%)
BA   147.41 (-0.59%)
DIS   121.00 (-0.44%)
S&P 500   3,279.93 (-0.91%)
DOW   26,463.07 (-0.74%)
QQQ   274.15 (-0.81%)
AAPL   109.91 (-4.69%)
MSFT   203.51 (-0.59%)
FB   271.43 (-3.35%)
GOOGL   1,653.16 (+6.18%)
AMZN   3,095.89 (-3.59%)
TSLA   398.84 (-2.92%)
NVDA   510.82 (-1.95%)
BABA   309.05 (-1.12%)
CGC   18.66 (-0.64%)
GE   7.37 (+0.00%)
MU   50.00 (-0.95%)
AMD   76.01 (-2.58%)
T   26.80 (+0.15%)
F   7.79 (-1.39%)
ACB   3.97 (-2.93%)
GILD   58.14 (-0.67%)
NIO   30.44 (-4.85%)
NFLX   494.47 (-1.93%)
BA   147.41 (-0.59%)
DIS   121.00 (-0.44%)
Log in
NASDAQ:ESTA

Establishment Labs Stock Forecast, Price & News

$24.60
-0.65 (-2.57 %)
(As of 10/30/2020 09:30 AM ET)
Add
Compare
Today's Range
$24.60
Now: $24.60
$24.60
50-Day Range
$17.25
MA: $19.42
$24.92
52-Week Range
$7.56
Now: $24.60
$29.78
Volume15 shs
Average Volume87,480 shs
Market Capitalization$574.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.3
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in 80 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.
Read More
Establishment Labs logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.08 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ESTA
CUSIPN/A
CIKN/A
Phone506 2434 2400
Employees487

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$89.57 million
Book Value$1.92 per share

Profitability

Net Income$-38,150,000.00

Miscellaneous

Market Cap$574.83 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$24.60
-0.65 (-2.57 %)
(As of 10/30/2020 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

How has Establishment Labs' stock been impacted by COVID-19 (Coronavirus)?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 66.7% and is now trading at $25.25.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Establishment Labs?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Establishment Labs
.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Establishment Labs
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings data on Thursday, August, 6th. The company reported ($0.45) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.01. The company earned $10.47 million during the quarter, compared to the consensus estimate of $14.40 million. Establishment Labs had a negative net margin of 56.74% and a negative return on equity of 69.87%.
View Establishment Labs' earnings history
.

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs updated its third quarter 2020 Pre-Market earnings guidance on Wednesday, October, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $22-23 million, compared to the consensus revenue estimate of $18.3 million.

What price target have analysts set for ESTA?

4 Wall Street analysts have issued 12 month price targets for Establishment Labs' shares. Their forecasts range from $20.00 to $33.00. On average, they expect Establishment Labs' stock price to reach $24.75 in the next twelve months. This suggests that the stock has a possible downside of 2.0%.
View analysts' price targets for Establishment Labs
.

Are investors shorting Establishment Labs?

Establishment Labs saw a drop in short interest in September. As of September 15th, there was short interest totaling 480,600 shares, a drop of 19.2% from the August 31st total of 595,100 shares. Based on an average daily trading volume, of 40,700 shares, the short-interest ratio is presently 11.8 days.
View Establishment Labs' Short Interest
.

Who are some of Establishment Labs' key competitors?

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:
  • Mr. Juan José Chacón Quirós, Founder, CEO & Exec. Director (Age 48, Pay $589k)
  • Ms. Renee M. Gaeta, Chief Financial Officer (Age 39, Pay $461.21k)
  • Mr. Salvador Santos Dada, Chief Operating Officer (Age 38, Pay $441.9k)
  • Mr. Roberto De Mezerville, Chief Technology Officer (Age 40)
  • David K. Erickson, VP of Investor Relations
  • Mr. Jeremy Livianu, Gen. Counsel & Assistant Company Sec. (Age 38)
  • Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 38)

When did Establishment Labs IPO?

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include CWM LLC (0.50%) and WINTON GROUP Ltd (0.05%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De and Nicholas Sheridan Lewin.
View institutional ownership trends for Establishment Labs
.

Which institutional investors are selling Establishment Labs stock?

ESTA stock was sold by a variety of institutional investors in the last quarter, including CWM LLC.
View insider buying and selling activity for Establishment Labs
.

Which institutional investors are buying Establishment Labs stock?

ESTA stock was acquired by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin.
View insider buying and selling activity for Establishment Labs
.

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $25.25.

How big of a company is Establishment Labs?

Establishment Labs has a market capitalization of $590.02 million and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 487 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is www.establishmentlabs.com.

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.